AnaptysBio, Inc. (ANAB):
AnaptysBio, Inc. (ANAB) closed its day with gain 0.82% and ended at the price of $66.03. ANAB stock is a part of Biotechnology industry and belongs to Healthcare sector. The stock traded volume of 0.18 million shares during its recent trading session while it’s an average volume stands around 0.44 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 0.42. Relative volume is ratio between current volume and 3-month average value, intraday adjusted.
Analysts’ consensus recommendation is observed at 1.40. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
To evaluate the ANAB recent performance, look at its past history: the stock sticks almost 1.84% during last week. It showed the change of 85.79% in last one month. It remained at 183.76% over last 3 months. The stock year to date performance is standing at 288.41%.
Relative Strength Index (RSI) is 69.44 and ATR value of company is 3.48. The stock volatility for month is 6.64% and for week it is 4.81%.The stock traded 335.27% to its 52 week low and was changed -10.77% from its 52 week high as of last close. ANAB’s value Change from Open was at 0.55% with a Gap of 0.27%.
USA based company AnaptysBio, Inc. (ANAB)’s latest closing price was 128.85% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 58.18% and 12.02% compared with the 20 Day Moving Average.
EPS Growth about ANAB:
EPS growth in next year is estimated to reach -53.80% while EPS growth estimate for this year is set at 25.20%.